iCeutica logo — company profile

iCeutica

Founded 2011 United States King Of Prussia, United States 6 employees Series Unknown Total: $5.08M Biotechnology, Health Care +1

General Information

Company Name iCeutica
Founded Year 2011
Location United States King Of Prussia, United States +2
Employees 6
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series Unknown
Social

Get notified when iCeutica moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About iCeutica

is a privately held pharmaceutical research and development company located in King of Prussia, PA. Founded in 2003, iCeutica applies their proprietary SoluMatrix™ Fine Particle Technology to both approved and development stage drug compounds, creating new branded medicines independently and in collaboration with selected pharmaceutical partners. The resulting products provide meaningful clinical benefits for patients and have clearly defined pathways to regulatory and commercial success. The company has four FDA approved and marketed prescription drugs that use SoluMatrix Fine Particle Technology - the pain drugs Zorvolex™, Tivorbex™, and Vivlodex™ and the prostate cancer drug Yonsa®. Additionally, iCeutica and their partners have several pipeline products in various stages of development. Their last investment was a $1.01M Venture Round on 21 March 2011. The investors of the last investment round are currently undisclosed. iCeutica operates within the Biotechnology, Health Care, and Pharmaceutical industries, headquartered in the United States.

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• - 21 Mar 2011
Debt Financing •••••• - 18 Jun 2010
Series B •••••• 1 •••• •••• 12 Jan 2007
Series A •••••• 1 •••• •••• 20 Jun 2005

iCeutica Alternatives & Competitors

iCeutica vs

Developing specialized cancer, CNS and infectious disease pharmaceutical products

2 employees
Biotechnology, Pharmaceutical
iCeutica vs

Revolutionizing Therapeutics through Cutting-Edge Drug Delivery Solutions

Series C
Biotechnology, Pharmaceutical
iCeutica vs

Multi-Service Pharmaceutical Contract Development Manufacturing Organization (CDMO)

Series Unknown
20 employees
Biotechnology, Pharmaceutical

FAQ About iCeutica

iCeutica is a privately held pharmaceutical research and development company located in King of Prussia, PA. iCeutica applies our proprietary SoluMatrix™ Fine Particle Technology to both approved and development stage drug compounds, creating new branded medicines independently and in collaboration...
iCeutica was founded in 2011.
iCeutica is headquartered in King Of Prussia, United States.
iCeutica operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
iCeutica has approximately 6 employees.
iCeutica has completed 4 funding rounds, raising a total of $5.08M. The latest funding stage is Series Unknown.
Top alternatives and competitors to iCeutica include Nanopharmaceutics, Inc., Apidel, CritiTech Particle Engineering Solutions, Bostal Drug Delivery, Micron Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
iCeutica and Nanopharmaceutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors iCeutica and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy